NCT02647437View on ClinicalTrials.gov

Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Schizophrenia
Interventions
DRUG

Levetiracetam

DRUG

Placebo

Trial Locations (1)

80045

University of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT02647437 - Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in Schizophrenia | Biotech Hunter | Biotech Hunter